ANEB vs ROST · $15.3M cap vs P/E 21, rev $21.13B
Anebulo Pharmaceuticals Inc (ANEB) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
ANEB does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
ANEB currently screens at market cap $15.3M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the ANEB and ROST stock pages for the full models.
Not investment advice.